• Open Access close
• Restricted close
• Open Source close
• Research data close
• Research software close
• Other research products close
• DE close
• CN close
• BR close
• IE close

Published as part of Wang, Cheng-Bin, He, Li & Huang, Jian-Bin, 2023, Two new species of Anoplophora Hope, 1839 from China (Coleoptera, Cerambycidae, Lamiinae), pp. 165-181 in Zootaxa 5277 (1) on page 176, DOI: 10.11646/zootaxa.5277.1.8, http://zenodo.org/record/7893137 FIGURES 9A–F. Anoplophora zibroides sp. nov., male, holotype: A–C, abdominal segment VIII; D–F, spiculum gastrale. A, D, dorsal views; B, E, ventral views; C, F, lateral views.

Additional file 2: Table S1. The 10 most abundant ARGs type presented in each Group (juvenile, adult and geriatric) of GPs. Table S3. Correlation analysis of Bacterial genus and ARGs. Table S4. Correlation analysis of Metabolic pathway, pathways in biosynthesis of antibiotic and ARGs.

ABSTRACT Objective: To describe the effects of balanced solution use on the short-term outcomes of patients with traumatic brain injury enrolled in BaSICS trial. Methods: Patients were randomized to receive either 0.9% saline or balanced solution during their intensive care unit stay. The primary endpoint was 90-day mortality, and the secondary outcomes were days alive and free of intensive care unit stay at 28 days. The primary endpoint was assessed using Bayesian logistic regression. The secondary endpoint was assessed using a Bayesian zero-inflated beta binomial regression. Results: We included 483 patients (236 in the 0.9% saline arm and 247 in the balanced solution arm). A total of 338 patients (70%) with a Glasgow coma scale score ≤ 12 were enrolled. The overall probability that balanced solutions were associated with higher 90-day mortality was 0.98 (OR 1.48; 95%CrI 1.04 - 2.09); this mortality increment was particularly noticeable in patients with a Glasgow coma scale score below 6 at enrollment (probability of harm of 0.99). Balanced solutions were associated with -1.64 days alive and free of intensive care unit at 28 days (95%CrI -3.32 - 0.00) with a probability of harm of 0.97. Conclusion: There was a high probability that balanced solutions were associated with high 90-day mortality and fewer days alive and free of intensive care units at 28 days. ClinicalTrials.gov:NCT02875873

Im Datensatz '7-Tage-Inzidenz von COVID-19 in Deutschland' werden die aktuellen 7-Tage-Inzidenzen der nach den Vorgaben des Infektionsschutzgesetzes - IfSG - an das RKI übermittelten COVID-19-Fälle veröffentlicht. Datengrundlage zur Berechnung der 7-Tage-Inzidenzen sind die an das RKI übermittelten COVID-19-Fälle. Eine detaillierte Dokumentation zur Erhebung der Daten zum Infektionsgeschehen ist im Datensatz 'SARS-CoV-2-Infektionen in Deutschland' enthalten. Die für die Berechnung der 7-Tage-Inzidenz notwendigen Bevölkerungsdaten bezieht das RKI durch das Statistisches Bundesamt (Destatis), Referat F24 | Bevölkerungsfortschreibung, Ausländer- und Integrationsstatistiken.